Analysts at StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on ALIM. Alliance Global Partners raised shares of Alimera Sciences from a “neutral” rating […]
Alimera Sciences (NASDAQ:ALIM – Get Rating) was upgraded by equities research analysts at Alliance Global Partners from a “neutral” rating to a “buy” rating in a note issued to investors on Monday, The Fly reports. Other research analysts also recently issued research reports about the company. HC Wainwright cut their target price on Alimera Sciences […]
Alliance Global Partners upgraded shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) from a neutral rating to a buy rating in a research report report published on Monday, The Fly reports. A number of other research firms have also issued reports on ALIM. Craig Hallum reduced their target price on shares of Alimera Sciences from […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms have also weighed in on ALIM. Craig Hallum reduced their target price on shares of Alimera […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a report released on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued research reports about the stock. Craig Hallum cut their price objective on shares of Alimera Sciences from $18.00 to […]